SCHEMBL14068623

SCHEMBL14068623

COCCCN(Cc1cc2cc(C)ccc2[nH]c1=O)C(=O)c1cccc(Cl)c1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 4/20 0.81
KDM4E B2RXH2 6/20 0.66
HSD17B10 Q99714 6/20 0.66
SMN1; SMN2 Q16637 3/20 0.66
ALDH1A1 P00352 3/20 0.66
LMNA P02545 2/20 0.66
HPGD P15428 2/20 0.66
HTT P42858 1/20 0.66
THRB P10828 1/20 0.65
TSHR P16473 2/20 0.63
KMT2A Q03164 4/20 0.60
TP53 P04637 4/20 0.60
MITF O75030 1/20 0.60
MAPK1 P28482 2/20 0.59
MAPT P10636 2/20 0.59
MEN1 O00255 2/20 0.55
USP2 O75604 2/20 0.55
RECQL P46063 1/20 0.55
OPRK1 P41145 1/20 0.54
POLB P06746 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14068804 0.90 RXFP1 (0.86) RXFP1KDM4EHSD17B10SMN1; SMN2ALDH1A1
SCHEMBL13496444 0.77 RXFP1 (0.68) RXFP1KDM4EHSD17B10SMN1; SMN2ALDH1A1
SCHEMBL13496432 0.73 KDM4E (0.80) RXFP1KDM4EHSD17B10SMN1; SMN2ALDH1A1
SCHEMBL13496399 0.72 KDM4E (0.80) RXFP1KDM4EHSD17B10ALDH1A1LMNA
SCHEMBL12594562 0.70 ALOX15 (0.75) RXFP1KDM4EHSD17B10SMN1; SMN2ALDH1A1
SCHEMBL12594566 0.70 ALOX15 (0.72) RXFP1KDM4EHSD17B10SMN1; SMN2ALDH1A1
SCHEMBL13496425 0.70 KDM4E (0.84) RXFP1KDM4EHSD17B10ALDH1A1LMNA
SCHEMBL13561457 0.70 ALOX15 (0.74) RXFP1KDM4EHSD17B10ALDH1A1LMNA
SCHEMBL13496422 0.69 ALOX15 (1.00) KDM4EHSD17B10SMN1; SMN2ALDH1A1LMNA
SCHEMBL14068783 0.69 KDM4E (0.68) KDM4EHSD17B10SMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008113006-A1 METHODS OF USING QUINOLINONE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-09-18 WO disclosed